Haley Gittleman1,2, Alexander Boscia1,2, Quinn T Ostrom1,3, Gabrielle Truitt1,2, Yi Fritz2, Carol Kruchko1, Jill S Barnholtz-Sloan1,2. 1. Central Brain Tumor Registry of the United States, Hinsdale, Illinois. 2. Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio. 3. Department of Medicine, Section of Epidemiology and Population Sciences, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
Abstract
Background: The goal of this study was to provide up-to-date and comprehensive statistics on incidence, survival, and prevalence rates for selected malignant brain and other CNS tumors in adults. Methods: The current study used data from the Central Brain Tumor Registry of the United States, provided by the Centers for Disease Control and Prevention, to examine incidence and data from the Surveillance, Epidemiology, and End Results program to examine survival and prevalence in 16 distinct malignant brain and other CNS histologies in adults (aged 20 y and older at diagnosis) from 2000-2014 overall and by sex, age group, race, and ethnicity. Results: Glioblastoma had the highest incidence (4.40 per 100000) and prevalence (9.23 per 100000). Ependymal tumors had the highest 5- and 10-year relative survivals (87.8% and 84.5%, respectively), while glioblastoma had the lowest 5- and 10-year relative survivals (5.4% and 2.7%, respectively). Females generally had better survival and lower prevalence than males. Younger adults tended to have better survival than older adults, and prevalence varied greatly by age and histology. While survival did not vary significantly by race, white adults had higher prevalence than the other race groups. Hispanics generally had better survival rates and lower prevalence than non-Hispanics. Conclusions: Survival varied greatly by age and ethnicity. Prevalence differed by sex, age, race, and ethnicity.
Background: The goal of this study was to provide up-to-date and comprehensive statistics on incidence, survival, and prevalence rates for selected malignant brain and other CNS tumors in adults. Methods: The current study used data from the Central Brain Tumor Registry of the United States, provided by the Centers for Disease Control and Prevention, to examine incidence and data from the Surveillance, Epidemiology, and End Results program to examine survival and prevalence in 16 distinct malignant brain and other CNS histologies in adults (aged 20 y and older at diagnosis) from 2000-2014 overall and by sex, age group, race, and ethnicity. Results:Glioblastoma had the highest incidence (4.40 per 100000) and prevalence (9.23 per 100000). Ependymal tumors had the highest 5- and 10-year relative survivals (87.8% and 84.5%, respectively), while glioblastoma had the lowest 5- and 10-year relative survivals (5.4% and 2.7%, respectively). Females generally had better survival and lower prevalence than males. Younger adults tended to have better survival than older adults, and prevalence varied greatly by age and histology. While survival did not vary significantly by race, white adults had higher prevalence than the other race groups. Hispanics generally had better survival rates and lower prevalence than non-Hispanics. Conclusions: Survival varied greatly by age and ethnicity. Prevalence differed by sex, age, race, and ethnicity.
Authors: Quinn T Ostrom; Haley Gittleman; Carol Kruchko; David N Louis; Daniel J Brat; Mark R Gilbert; Valentina I Petkov; Jill S Barnholtz-Sloan Journal: J Neurooncol Date: 2016-07-14 Impact factor: 4.130
Authors: Quinn T Ostrom; Haley Gittleman; Peter Liao; Toni Vecchione-Koval; Yingli Wolinsky; Carol Kruchko; Jill S Barnholtz-Sloan Journal: Neuro Oncol Date: 2017-11-06 Impact factor: 12.300
Authors: Quinn T Ostrom; Joshua B Rubin; Justin D Lathia; Michael E Berens; Jill S Barnholtz-Sloan Journal: Neuro Oncol Date: 2018-03-27 Impact factor: 12.300
Authors: David N Louis; Arie Perry; Guido Reifenberger; Andreas von Deimling; Dominique Figarella-Branger; Webster K Cavenee; Hiroko Ohgaki; Otmar D Wiestler; Paul Kleihues; David W Ellison Journal: Acta Neuropathol Date: 2016-05-09 Impact factor: 17.088
Authors: Otto Visser; Eva Ardanaz; Laura Botta; Milena Sant; Andrea Tavilla; Pamela Minicozzi Journal: Eur J Cancer Date: 2015-09-26 Impact factor: 9.162
Authors: Adriana Olar; Khalida M Wani; Kristin D Alfaro-Munoz; Lindsey E Heathcock; Hinke F van Thuijl; Mark R Gilbert; Terri S Armstrong; Erik P Sulman; Daniel P Cahill; Elizabeth Vera-Bolanos; Ying Yuan; Jaap C Reijneveld; Bauke Ylstra; Pieter Wesseling; Kenneth D Aldape Journal: Acta Neuropathol Date: 2015-02-21 Impact factor: 17.088
Authors: Adah S Zhang; Quinn T Ostrom; Carol Kruchko; Lisa Rogers; David M Peereboom; Jill S Barnholtz-Sloan Journal: Neuro Oncol Date: 2017-05-01 Impact factor: 12.300
Authors: Michele Ceccarelli; Floris P Barthel; Tathiane M Malta; Thais S Sabedot; Sofie R Salama; Bradley A Murray; Olena Morozova; Yulia Newton; Amie Radenbaugh; Stefano M Pagnotta; Samreen Anjum; Jiguang Wang; Ganiraju Manyam; Pietro Zoppoli; Shiyun Ling; Arjun A Rao; Mia Grifford; Andrew D Cherniack; Hailei Zhang; Laila Poisson; Carlos Gilberto Carlotti; Daniela Pretti da Cunha Tirapelli; Arvind Rao; Tom Mikkelsen; Ching C Lau; W K Alfred Yung; Raul Rabadan; Jason Huse; Daniel J Brat; Norman L Lehman; Jill S Barnholtz-Sloan; Siyuan Zheng; Kenneth Hess; Ganesh Rao; Matthew Meyerson; Rameen Beroukhim; Lee Cooper; Rehan Akbani; Margaret Wrensch; David Haussler; Kenneth D Aldape; Peter W Laird; David H Gutmann; Houtan Noushmehr; Antonio Iavarone; Roel G W Verhaak Journal: Cell Date: 2016-01-28 Impact factor: 41.582
Authors: Beatrice S Melin; Jill S Barnholtz-Sloan; Margaret R Wrensch; Christoffer Johansen; Dora Il'yasova; Ben Kinnersley; Quinn T Ostrom; Karim Labreche; Yanwen Chen; Georgina Armstrong; Yanhong Liu; Jeanette E Eckel-Passow; Paul A Decker; Marianne Labussière; Ahmed Idbaih; Khe Hoang-Xuan; Anna-Luisa Di Stefano; Karima Mokhtari; Jean-Yves Delattre; Peter Broderick; Pilar Galan; Konstantinos Gousias; Johannes Schramm; Minouk J Schoemaker; Sarah J Fleming; Stefan Herms; Stefanie Heilmann; Markus M Nöthen; Heinz-Erich Wichmann; Stefan Schreiber; Anthony Swerdlow; Mark Lathrop; Matthias Simon; Marc Sanson; Ulrika Andersson; Preetha Rajaraman; Stephen Chanock; Martha Linet; Zhaoming Wang; Meredith Yeager; John K Wiencke; Helen Hansen; Lucie McCoy; Terri Rice; Matthew L Kosel; Hugues Sicotte; Christopher I Amos; Jonine L Bernstein; Faith Davis; Dan Lachance; Ching Lau; Ryan T Merrell; Joellen Shildkraut; Francis Ali-Osman; Siegal Sadetzki; Michael Scheurer; Sanjay Shete; Rose K Lai; Elizabeth B Claus; Sara H Olson; Robert B Jenkins; Richard S Houlston; Melissa L Bondy Journal: Nat Genet Date: 2017-03-27 Impact factor: 41.307
Authors: Timothy E Richardson; Mariano S Viapiano; James F Lyon; Varshini Vasudevaraja; Kanish Mirchia; Jamie M Walker; Robert J Corona; Lawrence S Chin; Ivy Tran; Matija Snuderl Journal: Acta Neuropathol Commun Date: 2021-06-30 Impact factor: 7.801
Authors: Camila Hirakata; Keli Lima; Bruna Oliveira De Almeida; Lívia Bassani Lins De Miranda; Katharine Gurgel Dias Florêncio; Luciana Costa Furtado; Leticia Veras Costa-Lotufo; João Agostinho Machado-Neto Journal: Oncol Lett Date: 2021-06-15 Impact factor: 2.967